Based on VigiBase, the World Health Organizations (WHO) adverse drug reaction database, intestinal obstructions are reported over 4.5 times more frequently with incretin-based drugs than with other diabetes medications [10]
Currently available GLP-1 receptor agonists in the United States include exenatide (Byetta, Bydureon BCise), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
6 Conclusion In conclusion, GLP-1, initially identified as an intestinal insulin-secreting molecule, exhibits multifaceted effects beyond blood sugar control, showing promise in enhancing cognitive function
Sandoz has been told its submission doesn't yet meet requirements and needs additional data pushing its expected launch from early 2026 to Q3 2026 at the earliest
For short trips (day trips or overnight stays): In-use multi-dose pens can be carried at room temperature in their protective case, within their permitted in-use period Unopened pens should generally be kept refrigerated, though some may be kept at room temperature for limited periods (check your specific product information) Use an insulated medication travel case to protect from temperature extremes Avoid leaving medication in cars , particularly during warm weather or in direct sunlight Keep medication in hand luggage when flying, never in checked baggage where temperatures may fall below freezing For longer journeys requiring refrigeration: Use a medical-grade cooling case or insulated travel wallet with ice packs designed for medication transport Avoid direct contact between ice packs and medication pens , as this may cause freezing
Case Study: Transforming Health with GLP-1 Injections in Lafayette, LA At MinuteMed Walk-In Clinic in Lafayette, LA , we are dedicated to offering innovative, evidence-based treatments that improve lives
